ERBB2 and breast carcinoma: TNBC tissues do not express estrogen receptor alpha (ERα), progesterone receptor (PR), and epidermal growth factor receptor 2 (HER2/neu) [3]; this is why these tumors are immune to hormonal and HER2-targeting therapies commonly used for breast cancer treatment.